DavidWmScharpMD

Transplantation

President & CEO, Prodo Laboratories Chairman of the Board, Scharp Technologies Scientific Director, The Scharp-Lacy Research Institute

Dr. Scharp is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

23 citations
Executive Summary of IPITA-TTS Opinion Leaders Report on the Future of β-Cell Replacement.
James F. Markmann, Stephen T. Bartlett, Paul Johnson, Olle Korsgren, Bernhard J. Hering
Transplantation. 2016-06-21
48 citations
Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement
Stephen T. Bartlett, James F. Markmann, Paul Johnson, Olle Korsgren, Bernhard J. Hering
Transplantation. 2016-02-01
3 citations
Simultaneous silencing of multiple RB and p53 pathway members induces cell cycle reentry in intact human pancreatic islets
Stanley Tamaki, Christopher D. Nye, Euan M. Slorach, David Scharp, Helen M. Blau
BMC Biotechnology. 2014-10-11

Novel Thermal Reversible Polymer (TRG) For Human Islet Encapsulation And ImplantaNational Institute Of Diabetes And Digestive And Kidney Diseases2011
Core--Human Islet IsolationNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1997
Clinical Islet TransplantationNational Center For Research Resources1996
Clinical Trials On Human Islet TransplantationNational Institute Of Diabetes And Digestive And Kidney Diseases1988–1993
Clinical Islet Transplantation In Diabetes MellitusNational Center For Research Resources1990